Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Pozycja w akcjach #10934
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Cena akcji
$24.43
Kapitalizacja rynkowa
$246.02M
Zmiana (1 dzień)
-2.83%
Zmiana (1 rok)
-14.57%
Kraj
FR
Handel Eurobio Scientific Société anonyme (ALERS)

Kategoria

Zyski dla Eurobio Scientific Société anonyme (ALERS)
Zyski w Dec 2025 TTM: $9.16M
Według najnowszych raportów finansowych Eurobio Scientific Société anonyme, obecny zysk firmy wynosi $9.16M. W roku 2023 firma osiągnęła zysk w wysokości $7.71M, spadek w porównaniu do zysku z roku 2022, który wynosił $31.84M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Eurobio Scientific Société anonyme od 2007 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $9.16M 39.69%
2024 $6.56M -15.00%
2023 $7.71M -75.78%
2022 $31.84M -60.74%
2021 $81.09M -17.68%
2020 $98.51M 53,765.43%
2019 $182.88K -105.65%
2018 $-3.24M -70.90%
2017 $-11.13M 28.22%
2016 $-8.68M 23.50%
2015 $-7.03M -10.09%
2014 $-7.82M -20.26%
2013 $-9.81M 10.74%
2012 $-8.86M -16.61%
2011 $-10.62M -12.50%
2010 $-12.14M -9.16%
2009 $-13.36M -12.97%
2008 $-15.35M 31.03%
2007 $-11.72M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$8.14B 88,757.50%
US
$4.60B 50,132.83%
US
$6.14B 66,919.05%
IE
$3.74B 40,763.31%
US
$1.30B 14,074.39%
US